UK Biotech Firm Sets Eyes on Riyadh to Catalyze the Next Generation of Health Unicorns

In an ambitious move poised to reshape the landscape of healthcare innovation, a prominent UK biotech company has announced its plans to establish a significant presence in Riyadh, Saudi Arabia. This strategic decision highlights Riyadh's growing prominence as a burgeoning hub for health and biotechnology, paving the way for the creation of new health-focused startups, often referred to as "unicorns" due to their ability to achieve valuations exceeding $1 billion.

Continue reading